TBPH Operating Expenses
Theravance Biopharma Inc · Operating Expenses
TBPH Operating Expenses
Latest reported$88.59Mperiod ending
TBPH Operating Expenses ($120.35M → $88.59M)
Annual operating expenses
High-resolution chart · PNG
TBPH operating expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Expenses (USD) |
|---|---|
| 115,195,000 | |
| 73,687,000 | |
| 72,838,000 | |
| 79,911,000 | |
| 119,438,000 | |
| 369,484,000 | |
| 325,329,000 | |
| 298,406,000 | |
| 269,479,000 | |
| 226,221,000 | |
| 219,368,000 | |
| 240,169,000 | |
| 156,510,000 | |
| 139,720,000 | |
| 120,345,000 |